pI: 9.6249 |
Length (AA): 1601 |
MW (Da): 192246 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 14 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
266 | 477 | 1tzd (A) | 204 | 458 | 24.00 | 0 | 0.93 | -0.09 | -0.31 |
291 | 478 | 2a98 (A) | 466 | 683 | 22.00 | 0 | 0.52 | -0.16 | -0.48 |
253 | 478 | 4o4f (A) | 38 | 266 | 23.00 | 0 | 0.98 | 0.419762 | -0.26 |
257 | 480 | 2iew (A) | 32 | 360 | 29.00 | 0 | 1 | 0.357513 | -0.13 |
292 | 469 | 1w2d (B) | 245 | 452 | 30.00 | 0.95 | 0.74 | 0.131081 | 0.33 |
501 | 1452 | 1epw (A) | 285 | 1278 | 25.00 | 0.005 | 0.89 | 0.464528 | 1.98 |
802 | 1025 | 3uau (A) | 81 | 315 | 29.00 | 0.45 | 0.35 | 0.0768126 | 1.37 |
1329 | 1554 | 4tql (A) | 10 | 231 | 18.00 | 0.73 | 0.08 | 0.283762 | -0.45 |
251 | 478 | 2a98 (A) | 425 | 683 | 20.00 | 0.000000000028 | 0.9 | 0.100589 | -0.13 |
269 | 473 | 4frf (A) | 45 | 274 | 26.00 | 0.00021 | 0.98 | 0.382405 | 0.02 |
276 | 480 | 2iew (A) | 63 | 360 | 31.00 | 0 | 0.97 | 0.347205 | -0.07 |
578 | 1376 | 5czz (A) | 248 | 1049 | 23.00 | 0.000047 | 0.89 | 0.363887 | 1.93 |
713 | 983 | 3obr (A) | 863 | 1196 | 31.00 | 0.39 | 0.05 | -0.0283191 | 1.81 |
1048 | 1235 | 2ap3 (A) | 11 | 195 | 17.00 | 0.21 | 0.07 | 0.213573 | -0.24 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 40 hs, Ring, Female Gametocyte, Male Gametocyte. | Otto TD Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 48 hs, merozoite, Oocyst, Sporozoite. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | gametocyte. | PlasmoDB |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_128105)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_41900 | Inositol polyphosphate kinase family protein |
Candida albicans | CaO19.8622 | similar to InositolP6 kinase |
Candida albicans | CaO19.1007 | similar to InositolP6 kinase |
Caenorhabditis elegans | CELE_F30A10.3 | Protein F30A10.3 |
Dictyostelium discoideum | DDB_G0278739 | inositol phosphate kinase |
Dictyostelium discoideum | DDB_G0283863 | hypothetical protein |
Drosophila melanogaster | Dmel_CG10082 | CG10082 gene product from transcript CG10082-RA |
Entamoeba histolytica | EHI_051050 | inositol hexaphosphate kinase, putative |
Entamoeba histolytica | EHI_106120 | inositol hexakisphosphate kinase, putative |
Homo sapiens | ENSG00000161896 | inositol hexakisphosphate kinase 3 |
Homo sapiens | ENSG00000176095 | inositol hexakisphosphate kinase 1 |
Leishmania braziliensis | LbrM.14.0340 | inositol polyphosphate kinase-like protein, putative |
Leishmania donovani | LdBPK_140340.1 | inositol polyphosphate kinase-like protein, putative |
Leishmania infantum | LinJ.14.0340 | inositol polyphosphate kinase-like protein, putative |
Leishmania major | LmjF.14.0340 | inositol polyphosphate kinase-like protein, putative |
Leishmania mexicana | LmxM.14.0340 | inositol polyphosphate kinase-like protein, putative |
Loa Loa (eye worm) | LOAG_03580 | hypothetical protein |
Loa Loa (eye worm) | LOAG_11012 | inositol polyphosphate kinase |
Mus musculus | ENSMUSG00000032594 | inositol hexaphosphate kinase 1 |
Mus musculus | ENSMUSG00000024210 | inositol hexaphosphate kinase 3 |
Neospora caninum | NCLIV_002970 | hypothetical protein |
Onchocerca volvulus | OVOC1377 |
|
Plasmodium berghei | PBANKA_1414600 | inositol polyphosphate kinase, putative |
Plasmodium falciparum | PF3D7_1316100 | inositol polyphosphate kinase, putative |
Plasmodium knowlesi | PKNH_1416800 | inositol polyphosphate kinase, putative |
Plasmodium vivax | PVX_122630 | inositol polyphosphate kinase, putative |
Plasmodium yoelii | PY06556 | inositol hexakisphosphate kinase |
Saccharomyces cerevisiae | YDR017C | inositol polyphosphate kinase KCS1 |
Trypanosoma brucei gambiense | Tbg972.7.4970 | inositol polyphosphate kinase-like protein, putative |
Trypanosoma brucei | Tb927.7.4400 | inositol hexakisphosphate kinase |
Trypanosoma congolense | TcIL3000_7_3620 | inositol polyphosphate kinase-like protein, putative |
Trypanosoma cruzi | TcCLB.506985.60 | inositol polyphosphate kinase-like protein, putative |
Trypanosoma cruzi | TcCLB.504213.90 | inositol polyphosphate kinase-like protein, putative |
Toxoplasma gondii | TGME49_208070 | inositol polyphosphate kinase |
Trichomonas vaginalis | TVAG_476200 | inositol polyphosphate kinase, putative |
Trichomonas vaginalis | TVAG_410270 | transcription factor, putative |
Trichomonas vaginalis | TVAG_574700 | kcs1 protein, putative |
Trichomonas vaginalis | TVAG_175750 | kcs1 protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.4400 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.4400 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.4400 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.7.4400 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_1414600 | Plasmodium berghei | Dispensable | plasmo |
TGME49_208070 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.